X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (661) 661
index medicus (521) 521
male (455) 455
female (417) 417
middle aged (379) 379
adult (342) 342
oncology (324) 324
lymphoma, extranodal nk-t-cell - pathology (310) 310
aged (292) 292
prognosis (267) 267
lymphomas (264) 264
hematology (240) 240
chemotherapy (229) 229
lymphoma, extranodal nk-t-cell - diagnosis (201) 201
young adult (185) 185
t-cell lymphoma (184) 184
adolescent (176) 176
lymphoma, extranodal nk-t-cell - therapy (172) 172
nasal-type (169) 169
cancer (168) 168
non-hodgkin's lymphomas (150) 150
t-cell (149) 149
t cells (144) 144
lymphoma, extranodal nk-t-cell - drug therapy (142) 142
lymphoma, extranodal nk-t-cell - mortality (142) 142
treatment outcome (141) 141
lymphoma (140) 140
antineoplastic combined chemotherapy protocols - therapeutic use (137) 137
pathology (137) 137
retrospective studies (133) 133
radiotherapy (130) 130
neoplasm staging (109) 109
immunohistochemistry (108) 108
aged, 80 and over (107) 107
extranodal nk/t-cell lymphoma (107) 107
nose neoplasms - pathology (106) 106
l-asparaginase (104) 104
epstein-barr virus (100) 100
diagnosis (98) 98
medicine & public health (98) 98
care and treatment (94) 94
lymphoma, extranodal nk-t-cell - metabolism (90) 90
disease-free survival (89) 89
extranodal natural killer/t-cell lymphoma (89) 89
epstein-barr-virus (88) 88
analysis (86) 86
non-hodgkins-lymphoma (86) 86
diagnosis, differential (84) 84
nasal type (83) 83
t cell lymphoma (81) 81
expression (79) 79
medical prognosis (79) 79
biopsy (78) 78
extranodal nk (75) 75
combined modality therapy (74) 74
fatal outcome (73) 73
leukemia (72) 72
survival (71) 71
child (70) 70
prognostic-factors (69) 69
lymphoma, extranodal nk-t-cell - genetics (67) 67
lymphoma, extranodal nk-t-cell - virology (66) 66
survival analysis (66) 66
transplantation (66) 66
classification (63) 63
peripheral t-cell (63) 63
hemic and lymphatic diseases (61) 61
health aspects (60) 60
extranodal natural killer (59) 59
patients (59) 59
radiation therapy (59) 59
research (58) 58
extranodal nk/t cell lymphoma (57) 57
survival rate (57) 57
kaplan-meier estimate (55) 55
neoplasms (54) 54
nk/t-cell lymphoma (54) 54
follow-up studies (53) 53
natural killer cells (53) 53
tumors (53) 53
asparaginase - administration & dosage (52) 52
killer cells (52) 52
lymphoma, extranodal nk-t-cell - complications (52) 52
therapy (52) 52
tomography, x-ray computed (52) 52
killer cells, natural - pathology (51) 51
/t-cell lymphoma (50) 50
nose neoplasms - therapy (49) 49
case report (48) 48
lymphoma, extranodal nk-t-cell - radiotherapy (48) 48
lymphocytes (46) 46
lymphocytes t (46) 46
nose neoplasms - mortality (46) 46
herpesvirus 4, human - genetics (44) 44
lymphoma, extranodal nk-t-cell - immunology (44) 44
abridged index medicus (43) 43
development and progression (43) 43
immunophenotyping (43) 43
medical colleges (43) 43
phase-ii (41) 41
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (829) 829
Chinese (16) 16
Korean (12) 12
Japanese (11) 11
Turkish (4) 4
Spanish (3) 3
French (2) 2
German (2) 2
Portuguese (2) 2
Russian (2) 2
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Turkish Journal of Hematology, ISSN 1300-7777, 2016, Volume 33, Issue 1, pp. 74 - 75
Journal Article
Seminars in Hematology, ISSN 0037-1963, 01/2014, Volume 51, Issue 1, pp. 42 - 51
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 9, pp. 1240 - 1247
Journal Article
Leukemia, ISSN 0887-6924, 2018, Volume 33, Issue 6, pp. 1451 - 1462
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 01/2016, Volume 145, Issue 1, pp. 46 - 54
Objectives: To investigate the clinicopathologic features of extranodal natural killer/T-cell lymphoma (ENKTL) not preceded by another Epstein-Barr virus... 
Immunophenotype | SINGLE-CENTER | PATHOLOGY | PERIPHERAL T-CELL | Children and adolescence | HEALTH-ORGANIZATION CLASSIFICATION | Extranodal NK/T-cell lymphoma | NASAL-TYPE | China | LYMPHOPROLIFERATIVE DISORDER | Epstein-Barr virus | PATIENT | Clinicopathologic features | OF-THE-LITERATURE | EBV-INFECTION | Occurrence | EXPRESSION | EPSTEIN-BARR-VIRUS
Journal Article
Medicine, ISSN 0025-7974, 08/2018, Volume 97, Issue 34, p. e12028
Journal Article
Leukemia, ISSN 0887-6924, 10/2017, Volume 31, Issue 10, pp. 2219 - 2227
RUNX3, runt-domain transcription factor, is a master regulator of gene expression in major developmental pathways. It acts as a tumor suppressor in many... 
ONCOLOGY | FAMILY GENES | IN-VIVO | GROWTH | GENE-EXPRESSION PROFILES | C-MYC | TUMOR-SUPPRESSOR | PROTEIN MISLOCALIZATION | OVARIAN-CANCER | HEMATOLOGY | EPSTEIN-BARR-VIRUS | BET BROMODOMAINS | Nose Neoplasms - etiology | RNA, Small Interfering - genetics | Up-Regulation | Lymphoma, Extranodal NK-T-Cell - etiology | Core Binding Factor Alpha 3 Subunit - antagonists & inhibitors | Humans | Gene Expression Regulation, Neoplastic | Molecular Targeted Therapy | Recombinant Fusion Proteins - metabolism | Lymphoma, Extranodal NK-T-Cell - genetics | Proto-Oncogene Proteins c-myc - physiology | RNA Interference | Cell Transformation, Neoplastic - genetics | Cell Division | Nose Neoplasms - metabolism | Binding Sites | Genes, Reporter | Nose Neoplasms - pathology | Nose Neoplasms - genetics | Protein Interaction Mapping | Azepines - pharmacology | Core Binding Factor Alpha 3 Subunit - physiology | Triazoles - pharmacology | Enhancer Elements, Genetic | Lymphoma, Extranodal NK-T-Cell - pathology | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Cell Line, Tumor | Core Binding Factor Alpha 3 Subunit - genetics | Transcription, Genetic - genetics | Genetic Vectors | Apoptosis | Lymphoma, Extranodal NK-T-Cell - metabolism | Transcription factors | Care and treatment | Development and progression | Lymphomas | Genetic aspects | Gene expression | Health aspects | Oncogenes | Cell proliferation | Biotechnology | Chromatin | Immunoprecipitation | Lymphocytes T | T cell receptors | Myc protein | Lymphoma | Transfection | Developmental stages | Cell lines | Tumor suppressor genes | Inhibition | Natural killer cells | Binding sites | Runx3 protein | T-cell lymphoma | Tumors | Original
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 33, pp. 5594 - 5600
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2017, Volume 35, Issue 1, pp. 32 - 39
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 07/2017, Volume 66, Issue 7, pp. 877 - 890
Journal Article
by Yang, YN and Li, ZL and Chen, ZY and Liang, H
MEDICINE, ISSN 0025-7974, 08/2019, Volume 98, Issue 34, p. e16747
Rationale: Neurologic deficits are rare in patients with extranodal natural killer/T-cell lymphoma (NKTL), nasal type. We present a case that was initially... 
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | PROGNOSTIC-FACTORS | metastasis | tuberculous meningitis | EXTENSION | T-CELL | misdiagnosis | extranodal NK/T-cell lymphoma | Case studies | Nose cancer | Care and treatment | T cell lymphoma | Brain cancer | Diagnosis | Metastasis
Journal Article
Cancer, ISSN 0008-543X, 01/2013, Volume 119, Issue 2, pp. 348 - 355
BACKGROUND: Extranodal natural killer/T‐cell lymphoma, nasal type (ENKTL) is a distinct subtype of non‐Hodgkin lymphoma in which the upper aerodigestive tract... 
oxaliplatin | gemcitabine | asparaginase | extranodal natural killer/T‐cell | progression‐free survival | progression-free survival | extranodal natural killer/T-cell | (NK)/T-CELL LYMPHOMA | T-cell | PROGNOSTIC-FACTORS | PHASE-II | EFFECTIVE SALVAGE REGIMEN | BARR-VIRUS-DNA | extranodal natural killer | ONCOLOGY | NASAL-TYPE | ACUTE LYMPHOBLASTIC-LEUKEMIA | SYSTEMIC CHEMOTHERAPY | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Aluminum Hydroxide - administration & dosage | Chemoradiotherapy | Young Adult | Organoplatinum Compounds - administration & dosage | Lymphoma, Extranodal NK-T-Cell - therapy | Adult | Female | Bentonite - administration & dosage | Neoplasm Recurrence, Local - prevention & control | Deoxycytidine - administration & dosage | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Treatment Outcome | Head and Neck Neoplasms - pathology | Disease-Free Survival | Magnesium Hydroxide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Extranodal NK-T-Cell - pathology | Lymphoma, Extranodal NK-T-Cell - mortality | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Drug Combinations | Antimitotic agents | T cell lymphoma | Patient outcomes | Dosage and administration | Research | Drug therapy | Antineoplastic agents | Index Medicus | Abridged Index Medicus | Cancer
Journal Article